Eli Lilly's Next-Gen Obesity Drug Delivers Eye-Popping Weight LossInvestors Business Daily • 05/21/26
Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trialPRNewsWire • 05/21/26
Focus: Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors sayReuters • 05/21/26
Eli Lilly accuses church bishops, businessmen of fraud in Trulicity drug rebate schemeCNBC • 05/20/26
These 15 S&P 500 stocks could be contrarian ways to play the market's uneven rallyMarket Watch • 05/20/26
Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics' Pill Could Crash the Weight-Loss PartyThe Motley Fool • 05/19/26